InsidersTradesSigma
Track the 카이노스메드 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 카이노스메드 has published 1 public disclosures. Market capitalisation: €35.6bn. The latest transaction was filed on 17 March 2026 (Other). Among the most active insiders: 카이노스메드. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 28,349 of 29,063 companies
11.1
score / 100
Value11
Quality12
FCF yld-17%
Earn yld-22%
EV/EBITDA·
ROE-91%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 March 2026
关于 카이노스메드
Kainosmed 是一家在韩国交易所 (XKRX) 上市的医疗保健和制药公司。该公司专注于为医疗领域开发创新解决方案。